Cargando…
Harnessing NK Cell Checkpoint-Modulating Immunotherapies
During the host immune response, the precise balance of the immune system, regulated by immune checkpoint, is required to avoid infection and cancer. These immune checkpoints are the mainstream regulator of the immune response and are crucial for self-tolerance. During the last decade, various new i...
Autores principales: | Chauhan, Sachin Kumar Singh, Koehl, Ulrike, Kloess, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408278/ https://www.ncbi.nlm.nih.gov/pubmed/32640575 http://dx.doi.org/10.3390/cancers12071807 |
Ejemplares similares
-
Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
por: Oberschmidt, Olaf, et al.
Publicado: (2017) -
Harnessing NK cells for cancer immunotherapy: immune checkpoint receptors and chimeric antigen receptors
por: Kim, Nayoung, et al.
Publicado: (2021) -
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
por: Seliger, Barbara, et al.
Publicado: (2022) -
Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors
por: Rajani, Karishma R., et al.
Publicado: (2015) -
Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma
por: Reina-Ortiz, Chantal, et al.
Publicado: (2022)